0 Views
0 Likes
0 Shares
0 Comments
Read article ↗

StayCurrentMD

View profile →

Article

A Comparison of Smoflipid® and Intralipid® in the Early Management of Infants with Intestinal Failure

Published: Reading: 1 min

Topic overview

Retrospective study comparing Smoflipid® versus Intralipid® lipid emulsions in 44 infants with intestinal failure found no significant difference in cholestasis incidence (76% vs 91%), but Smoflipid patients resolved hyperbilirubinemia faster. Smoflipid may offer greatest benefit for infants unable to tolerate enteral feeds.

Keywords

Intestinal Failure Parenteral Nutrition Cholestasis Lipid Emulsions Neonatal Nutrition Conjugated Hyperbilirubinemia

Hashtags

#IntestinalFailure #ParenteralNutrition #NeonatalCholestasis #PediatricGastroenterology

Full article text

Full article text not available for this entry
How to cite: GlobalCastMD. A Comparison of Smoflipid® and Intralipid® in the Early Management of Infants with Intestinal Failure. GlobalCastMD Medical Library. 2019-10-29. https://library.globalcastmd.com/article/1765

Comments

Loading comments...